Synopsys (SNPS) CFO 10b5-1 Trades: Option Exercises and Share Sales

Rhea-AI Filing Summary

Shelagh Glaser, Chief Financial Officer of Synopsys, filed a Form 4 reporting option exercises and share transactions executed pursuant to a Rule 10b5-1 trading plan. The report shows transactions dated 09/05/2025 under a 10b5-1 plan adopted January 13, 2025. On that date Ms. Glaser acquired 2,612 shares via a $348.17-priced non-qualified option and 1,043 shares via a $354.45-priced non-qualified option. The Form also reports corresponding dispositions of 2,612 and 1,043 shares at $609.77. Beneficial ownership totals shown after the transactions include 17,929, 16,360 and 15,317 shares in various lines. The Form 4 was submitted by POA Liz Ramirez on 09/09/2025.

Positive

• Transactions executed under a Rule 10b5-1 plan (adopted January 13, 2025) which provides an affirmative defense for pre-established trades
• Documented option exercises and corresponding share trades with explicit exercise prices ($348.17 and $354.45) and sale price ($609.77) reported

Negative

• None.

Insights

Financial Analyst

TL;DR: CFO executed option exercises and share sales under a pre-established 10b5-1 plan on 09/05/2025.

The filing documents simultaneous option exercises and share dispositions for Shelagh Glaser executed pursuant to a Rule 10b5-1 plan adopted January 13, 2025. The exercises relate to non-qualified stock options with strike prices of $348.17 and $354.45 producing 2,612 and 1,043 underlying shares respectively. The reported sales prices are $609.77 per share for each disposed tranche. These are routine insider liquidity events documented under an affirmative defense trading plan and do not include additional commentary on use of proceeds or changes to compensation terms.

Corporate Governance Expert

TL;DR: Transactions were conducted under a documented 10b5-1 plan, providing procedural compliance but no new governance actions.

The Form 4 indicates that the CFO's trades were effected pursuant to a 10b5-1 trading plan adopted earlier in 2025 and the filing was executed by a power of attorney. From a governance perspective, the filing shows compliance with insider-trading protocols; it does not disclose any management departures, new equity grants beyond the listed exercises, or governance changes. All material details in the filing are transaction-level disclosures consistent with Section 16 reporting requirements.

Insider Trade Summary

Net Seller: 3,655 shares ($2,228,709)

Net Sell 6 txns

Insider Glaser Shelagh

Role CFO

Sold 3,655 shs ($2.23M)

Type	Security	Shares	Price	Value
Exercise	Non-Qualified Stock Option (right to buy)	2,612	$0.00	--
Exercise	Non-Qualified Stock Option (right to buy)	1,043	$0.00	--
Exercise	Common Stock	2,612	$348.17	$909K
Sale	Common Stock	2,612	$609.77	$1.59M
Exercise	Common Stock	1,043	$354.45	$370K
Sale	Common Stock	1,043	$609.77	$636K

Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 13,061 shares (Direct); Common Stock — 17,929 shares (Direct)

Footnotes (1)

1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted January 13, 2025. 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Glaser Shelagh

(Last) (First) (Middle)

675 ALMANOR AVENUE

(Street)

SUNNYVALE CA 94085

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SYNOPSYS INC [ SNPS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

3. Date of Earliest Transaction (Month/Day/Year)
09/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/05/2025		M		2,612	A	$348.17	17,929	D
Common Stock	09/05/2025		S		2,612	D	$609.77	15,317	D
Common Stock	09/05/2025		M		1,043	A	$354.45	16,360	D
Common Stock	09/05/2025		S		1,043	D	$609.77	15,317	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$348.17	09/05/2025		M(1)			2,612	12/02/2023(2)	12/02/2029	Common Stock	2,612	$0.0	13,061	D
Non-Qualified Stock Option (right to buy)	$354.45	09/05/2025		M(1)			1,043	02/17/2024(2)	02/17/2030	Common Stock	1,043	$0.0	6,409	D

Explanation of Responses:

1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted January 13, 2025.

2. 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.

	By: POA Pursuant Liz Ramirez For: Shelagh Glaser	09/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did SNPS CFO Shelagh Glaser report on Form 4?

The Form 4 reports option exercises and share transactions on 09/05/2025: exercises of 2,612 and 1,043 shares (strikes $348.17 and $354.45) and dispositions of 2,612 and 1,043 shares at $609.77.

Were these trades part of a 10b5-1 trading plan for SNPS?

Yes. The filing states the transactions were effected pursuant to a Rule 10b5-1 trading plan adopted January 13, 2025.

How many Synopsys shares did the Form 4 show as beneficially owned after the reported transactions?

The Form lists beneficial ownership amounts after transactions including 17,929, 16,360 and 15,317 shares on various reported lines.

Who signed the Form 4 for Shelagh Glaser and when was it filed?

The Form 4 was submitted by POA Liz Ramirez for Shelagh Glaser and is dated 09/09/2025 on the signature line.

What were the exercise prices and expiration periods for the reported options?

The reported non-qualified stock options have exercise prices of $348.17 and $354.45; vesting/exercisability schedules reference grant dates 12/02/2023 and 02/17/2024 with expirations 12/02/2029 and 02/17/2030 respectively.